Digital Digital marketing worked. Now pharma must reorganise around ... Remember when I said that patients are coming to doctors with formed opinions – if they come to physicians at all?
Digital We can’t fix modern healthcare with 1950s solutions. AI is t... In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.
Digital Digitalisation of pharma in 2025: What’s holding firms back? The ability to operate with real-time data, integrated systems, and validated automation is now essential.
Digital Monzo-meets-medicine? A prescription for just-in-time health... Challenger brand thinking has transformed industries all around us. What if we applied the same to healthcare?
Digital Sovereign AI as the backbone of LSHC GCC innovation: Priorit... In recent times, Global Capability Centres (GCCs) have become drivers of innovation for global Life Sciences and Healthcare (LSHC) companies.
News J&J adds rare disease wAIHA to Imaavy's potential uses Johnson & Johnson's 'Swiss army knife' drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
